Anpario plc (AIM:ANP)

Market Cap	82.81M
Revenue (ttm)	32.72M
Net Income (ttm)	3.02M
Shares Out	20.45M
EPS (ttm)	0.18
PE Ratio	22.54
Forward PE	16.54
Dividend	0.11 (2.65%)
Ex-Dividend Date	Nov 14, 2024

Volume	11,156
Average Volume	41,485
Open	403.25
Previous Close	405.00
Day's Range	401.75 - 407.25
52-Week Range	225.00 - 488.55
Beta	0.65
RSI	39.56
Earnings Date	Mar 26, 2025

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 109
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2023, Anpario's revenue was 31.00 million, a decrease of -6.36% compared to the previous year's 33.10 million. Earnings were 2.53 million, a decrease of -23.46%.